Adult and Pediatric Hemoconcentrators Market, By Product Type, By End User, By Geography

Adult And Pediatric Hemoconcentrators Market is estimated to be valued at USD 14.3 Mn in 2026 and is expected to reach USD 17.7 Mn by 2033, growing at a compound annual growth rate (CAGR) of 3.3% from 2026 to 2033.

Hemoconcentrators are medical devices used by healthcare professionals or perfusionist (health care professional who operates heart-lung bypass equipment), to concentrate red blood cells and remove excess fluid from the bloodstream during surgery. During surgery, the entire blood volume of the patient passes through the hemoconcentrator.

Hemoconcentrators is gaining significant traction in cardio bypass surgery, as it reduces the need for homologous blood and blood products by providing patients with their own concentrated whole blood. It maintains the desired hematocrit level for oxygen transport to tissues; it decreases the risk of post-operative bleeding through the retention of platelets and plasma coagulation proteins; it maintains oncotic pressure by retaining plasma proteins while quickly and gently removing excess plasma water; and minimizes the need for diuretic use, which may be contraindicated for some patients.

Market Dynamics

Hemoconcentrators are widely used as gold standard for removal of fluid during cardio bypass surgery. Cardiovascular diseases are the most common and life threatening diseases.

For instance, according to the data published by Centers of Disease Control and Prevention (CDC), heart diseases are the leading cause of death in the U.S. Annually around 630,000 people in the U.S. die from heart diseases, which is around 1 in every 4 deaths. According to the same source in the U.S., one patient suffers from heart attack in every 40 seconds. Each minute, more than one person in the U.S. dies from heart disease.

Such high prevalence of cardiovascular diseases in key regions such as North America and Asia-Pacific is expected to be a major factor propelling demand for hemoconcentrators and drive global adult and pediatric hemoconcentrators market growth over the forecast period.

Furthermore, key players in the market are adopting strategic partnership and collaboration activities for expanding its presence in the market. For instance, in 2016, MEDIVATORS Inc. (a Cantel Medical Corporation company), a manufacturer of Hemocor HPH family hemoconcentrators expanded its direct sales operations in Canada by acquiring endoscope reprocessing business assets from its Canadian distributor, Vantage Endoscopy, Inc., a subsidiary of Diploma Canada Holdings Ltd.

Key features of the study

• This report provides in-depth analysis of adult and pediatric hemoconcentrators market and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2018 - 2026), considering 2017, as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by leading players
• It profiles leading players in the global adult and pediatric hemoconcentrators market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
• Key companies covered as a part of this study include Medivators Inc., Terumo Corporation, LivaNova, PLC, Maquet (a Getinge Group company), Medica S.p.A, and others
• Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
• The global adult and pediatric hemoconcentrators market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the adult and pediatric hemoconcentrators market

Market Segmentation

• By Product Type
  • Adult Hemoconcentrators
  • Pediatric Hemoconcentrators
• By End User
  • Hospital
  • Ambulatory Surgical Centers
  • Others
• By Region
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East & Africa
  • GCC Countries
  • Israel
  • Rest of Middle East & Africa
• Adult and Pediatric Hemoconcentrators Market Companies
  • Medivators Inc.
  • Terumo Corporation
  • LivaNova, PLC
  • Maquet (a Getinge Group company)
  • Medica S.p.A